Shinya Okazaki

Summary

Affiliation: Juntendo University School of Medicine
Country: Japan

Publications

  1. ncbi request reprint Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study
    Shinya Okazaki
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku Tokyo 113 8421 Japan
    Circulation 110:1061-8. 2004
  2. ncbi request reprint Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting
    Kazunori Shimada
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo Bunkyo, Tokyo 113 8421, Japan
    Int J Cardiol 94:87-92. 2004
  3. doi request reprint Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    J Cardiol . 2016
  4. doi request reprint Impact of stent length on clinical outcomes of first-generation and new-generation drug-eluting stents
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo, 113 8431, Japan
    Cardiovasc Interv Ther 31:114-21. 2016
  5. doi request reprint Plasma lipoprotein(a) predicts major cardiovascular events in patients with chronic kidney disease who undergo percutaneous coronary intervention
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Int J Cardiol 205:50-3. 2016
  6. doi request reprint Clinical outcomes following percutaneous coronary intervention before and after introduction of drug-eluting stent
    Ryo Naito
    Department of Cardiology, Juntendo University Graduate School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo, 113 8421, Japan
    Cardiovasc Interv Ther 30:338-46. 2015
  7. doi request reprint Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo, 113 8431, Japan
    Heart Vessels 31:441-8. 2016
  8. doi request reprint Impact of the HAS-BLED Score on Long-Term Outcomes After Percutaneous Coronary Intervention
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Am J Cardiol 116:527-31. 2015
  9. doi request reprint Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Am J Cardiol 115:157-60. 2015
  10. doi request reprint Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J)
    Katsumi Miyauchi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Cardiovasc Drugs Ther 23:409-13. 2009

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study
    Shinya Okazaki
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku Tokyo 113 8421 Japan
    Circulation 110:1061-8. 2004
    ..The present study investigated the effect of early statin treatment on plaque volume of a nonculprit lesion by serial volumetric intravascular ultrasound in patients with ACS...
  2. ncbi request reprint Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting
    Kazunori Shimada
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo Bunkyo, Tokyo 113 8421, Japan
    Int J Cardiol 94:87-92. 2004
    ..Monocytes/macrophages and neutrophils are activated by lipopolysaccharide (LPS) via CD14. Endothelial cells and smooth muscle cells are also stimulated by soluble CD14 (sCD14)-LPS complexes...
  3. doi request reprint Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    J Cardiol . 2016
    ..However, whether warfarin control is associated with reduced cardiovascular events and major bleeding events in patients undergoing PCI with triple antithrombotic therapy is uncertain...
  4. doi request reprint Impact of stent length on clinical outcomes of first-generation and new-generation drug-eluting stents
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo, 113 8431, Japan
    Cardiovasc Interv Ther 31:114-21. 2016
    ..71-1.04; P = 0.14]. Implanted stent length was significantly associated with a higher risk of MACEs in patients who received first-generation DESs, but not in patients who received the new-generation DESs. ..
  5. doi request reprint Plasma lipoprotein(a) predicts major cardiovascular events in patients with chronic kidney disease who undergo percutaneous coronary intervention
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Int J Cardiol 205:50-3. 2016
    ..We aimed to determine the role of Lp(a) on long-term outcomes in patients with CKD after PCI...
  6. doi request reprint Clinical outcomes following percutaneous coronary intervention before and after introduction of drug-eluting stent
    Ryo Naito
    Department of Cardiology, Juntendo University Graduate School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo, 113 8421, Japan
    Cardiovasc Interv Ther 30:338-46. 2015
    ..16, 95% CI 0.010-0.9, p = 0.035). All-cause mortality, cardiovascular and non-cardiovascular mortality at three years were comparable between pre-DES and DES era, despite the higher risk profiles of patients in DES era...
  7. doi request reprint Long-term effect of β-blocker in ST-segment elevation myocardial infarction in patients with preserved left ventricular systolic function: a propensity analysis
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku, Tokyo, 113 8431, Japan
    Heart Vessels 31:441-8. 2016
    ..40, p = 0.04], whereas β-blocker therapy was not associated with major adverse cardiac events (MACE) and all-cause death. β-Blocker is an effective treatment for AMI patients who underwent PCI with preserved LV systolic function...
  8. doi request reprint Impact of the HAS-BLED Score on Long-Term Outcomes After Percutaneous Coronary Intervention
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Am J Cardiol 116:527-31. 2015
    ..In conclusion, the HAS-BLED score could predict the risk of bleeding and mortality for patients who underwent PCI independent of the presence of atrial fibrillation. ..
  9. doi request reprint Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Am J Cardiol 115:157-60. 2015
    ..68, 95% confidence interval 1.03 to 2.70, p = 0.04). In conclusion, a high Lp(a) value (≥30 mg/dl) could be associated with a poor prognosis after PCI even for patients who achieved target lipid levels...
  10. doi request reprint Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J)
    Katsumi Miyauchi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Cardiovasc Drugs Ther 23:409-13. 2009
    ..To confirm this hypothesis, a multicenter randomized trial of CCBs treatment with azelnidipine or amlodipine will be conducted in hypertensive CAD patients undergoing elective percutaneous coronary intervention (PCI)...
  11. ncbi request reprint Impact of aspirin treatment on long-term outcome (over 10 years) after percutaneous coronary intervention
    Widi Njaman
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Int Heart J 47:37-45. 2006
    ..Aspirin treatment at the time of PCI significantly reduced the risk of death from any cause and cardiac death. The administration of aspirin had a positive impact on the over 10-year long-term outcomes of patients who underwent PCI...
  12. doi request reprint Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention
    Takatoshi Kasai
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Hypertens Res 31:235-41. 2008
    ..87 [1.18-2.96]) were at significant risk for increased cardiac events. In conclusion, the risk of cardiac events is significantly increased in patients with metabolic syndrome following PCI, irrespective of DM...
  13. pmc Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting
    Tetsuro Miyazaki
    Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan
    Lipids Health Dis 9:122. 2010
    ..We assessed lipid profiles, plasma CET activity, and in-stent intimal hyperplasia after fenofibrate treatment in patients who underwent elective coronary stenting...
  14. ncbi request reprint Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model
    Katsumi Miyauchi
    Department of Cardiovascular Medicine, Juntendo University, Tokyo, Japan
    Circ J 72:832-8. 2008
    ..The present study evaluated the ability of stent-based cerivastatin delivery to reduce stent-induced inflammatory responses and adverse effects on endothelial function, and to inhibit neointimal hyperplasia in a porcine coronary model...
  15. ncbi request reprint Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting
    Kazunori Shimada
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    Jpn Heart J 43:85-91. 2002
    ....
  16. doi request reprint Long-term prognosis and clinical characteristics of young adults (≤40 years old) who underwent percutaneous coronary intervention
    Hirokazu Konishi
    Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
    J Cardiol 64:171-4. 2014
    ..Limited data exist regarding the long-term prognosis of percutaneous coronary intervention (PCI) in young adults. The aim of this study was to retrospectively assess the long-term clinical outcomes in young patients who underwent PCI...
  17. ncbi request reprint Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patients
    Ryozo Nagai
    Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Circ J 72:515-20. 2008
    ....
  18. ncbi request reprint Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy
    Takatoshi Kasai
    Department of Cardiology, Juntendo University, School of Medicine, Tokyo, Japan
    Int J Cardiol 114:210-7. 2007
    ..Statins have been proven to reduce cardiac events and mortality. However, there are few studies dealing with the long-term efficacy of statin therapy following percutaneous coronary intervention (PCI)...
  19. ncbi request reprint Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials
    Matthias Briel
    Basel Institute for Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
    JAMA 295:2046-56. 2006
    ..The short-term effects of early treatment with statins in patients after the onset of acute coronary syndromes (ACS) for the outcomes of death, myocardial infarction (MI), and stroke are unclear...